Univec, Inc. (UNVC)
OTCMKTS · Delayed Price · Currency is USD
0.0026
-0.0003 (-10.34%)
Aug 15, 2025, 4:00 PM EDT
Univec Revenue
Univec had revenue of $10.71K in the quarter ending June 30, 2011, with 27.14% growth. This brings the company's revenue in the last twelve months to $28.63K, up 46.77% year-over-year. In the year 2006, Univec had annual revenue of $21.46K, down -73.64%.
Revenue (ttm)
28.63K
Revenue Growth
+46.77%
P/S Ratio
229.10
Revenue / Employee
9.54K
Employees
3
Market Cap
6.56M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2006 | 21.46K | -59.94K | -73.64% |
Dec 31, 2005 | 81.40K | -246.43K | -75.17% |
Dec 31, 2004 | 327.83K | -611.92K | -65.12% |
Dec 31, 2003 | 939.75K | -1.95M | -67.45% |
Dec 31, 2002 | 2.89M | -1.02M | -26.06% |
Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 1999 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 1998 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 1997 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
Univec News
- 7 months ago - Univec, Inc. Welcomes Michael Knight to Board of Directors - Accesswire